ArticleBMC infectious diseases2010
Symptoms and sources of Yersinia enterocolitica-infection: a case-control study.
Article in BMC infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 130 citations in OpenAlex.
- Prevalence and genomic insights into Yersinia enterocolitica in Southeastern China (2008-2022).Applied microbiology and biotechnology · 2025Article
- Current Challenges inMicroorganisms · 2025Review
- A case-control study and molecular epidemiology of yersiniosis in Aotearoa New Zealand.Journal of clinical microbiology · 2024Article
- Enteric Infection-Associated Reactive Arthritis: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2024Review
- Thyroid abscess associated with thyrotoxicosis caused by Yersinia enterocolitica subsp. palearctica in a patient with follicular adenoma of the thyroid gland.BMC infectious diseases · 2024Article
- The implication of viability and pathogenicity by truncated lipopolysaccharide in Yersinia enterocolitica.Applied microbiology and biotechnology · 2023Article
- Isolation, characterization and antimicrobial resistance of Yersinia enterocolitica from Polish cattle and their carcasses.BMC veterinary research · 2023Article
- Thymol-Loaded Polymeric Nanoparticles Improve the Postharvest Microbiological Safety of Blueberries.Food technology and biotechnology · 2023Article
- Toxigenic Properties ofToxins · 2022Review
- Evaluation of the Correlation between the mRNA Expression Levels ofPathogens (Basel, Switzerland) · 2021Article
- Yersiniosis in New Zealand.Pathogens (Basel, Switzerland) · 2021Review
- Genetic Diversity and Distribution of Virulence-Associated Genes inPathogens (Basel, Switzerland) · 2021Article
- Global Prevalence ofInternational journal of microbiology · 2021Review
- Rcs Phosphorelay Responses to Truncated Lipopolysaccharide-Induced Cell Envelope Stress inMolecules (Basel, Switzerland) · 2020Article
- Comparative genomic insights intoMicrobial genomics · 2020Article
- Pemphigus foliaceus complicated by sepsis of the aetiology ofPostepy dermatologii i alergologii · 2020Article
- Bioserotypes, Virulence Markers, and Antimicrobial Susceptibility ofBioMed research international · 2020Article
- Osmoregulated Periplasmic Glucans Transmit External Signals Through Rcs Phosphorelay Pathway inFrontiers in microbiology · 2020Article
- Prevalence of human pathogenic Yersinia enterocolitica in Swedish pig farms.Acta veterinaria Scandinavica · 2018Article
- The Most Important Virulence Markers ofGenes · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundYersinia enterocolitica (YE) is the causative agent of yersiniosis. YE encompass strains of diverse pathogenicity: YE biotypes 1B and 2-5 are considered pathogenic, whereas biotype 1A is in general considered nonvirulent. Also YE-like species, which can sometimes be misidentified as YE, are considered nonvirulent.
methodsIn order to study differences in clinical picture caused by different YE types and their possible sources a case-control study was conducted in 2006. In this case-control study, 295 case-patients with YE or YE-like finding and their 758 controls responded to the questionnaire about symptoms and possible sources of infection.
resultsStrains of pathogenic YE bio/serotypes 3-4/O:3 or 2/O:9 were found in 18%, YE biotype 1A in 65% and YE -like strains of 17% of the patients. Patients infected with the strains of pathogenic YE bio/serotypes were younger and had fever more often than those with BT 1A who suffered more from vomiting. Symptoms of reactive arthritis were reported by 10% of pathogenic YE infections, 3% of YE BT 1A, and 0.3% of the controls. Eating or tasting raw or medium done pork was a significant risk factor for pathogenic YE bio/serotype infection (OR 6.6; 95% CI 1.7-24.9) as well as eating in a canteen (OR 3.5; 95% CI 1.6-7.9). Imported fruits and berries were associated with increased risk of YE BT 1A finding.
conclusionsThe symptoms of the patients with YE BT 1A differed from yersiniosis caused by the classic pathogenic YE bio/serotypes. In addition, the patients with YE BT 1A had more protracted gastrointestinal disorders and unspecific complaints. Small children were overrepresented in classic pathogenic bio/serotypes while in BT 1A or YE-like species were not found among children younger than two years. This suggests the lacking virulence of the BT 1A strains. We can not, however, rule out the possibility that some strains of genetically heterogeneous group of BT 1A may cause an illness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.